Rallybio Corp. (RLYB)
16.94
+0.25
(+1.50%)
USD |
NASDAQ |
Sep 02, 16:00
17.05
+0.11
(+0.65%)
After-Hours: 20:00
Rallybio Cash from Investing (Quarterly) : 5.50M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.50M |
| March 31, 2026 | 17.90M |
| December 31, 2025 | 3.925M |
| September 30, 2025 | 29.23M |
| June 30, 2025 | 3.035M |
| March 31, 2025 | 11.08M |
| December 31, 2024 | -1.573M |
| September 30, 2024 | 22.20M |
| June 30, 2024 | 2.596M |
| March 31, 2024 | 10.26M |
| December 31, 2023 | 16.91M |
| September 30, 2023 | 3.07M |
| June 30, 2023 | 6.214M |
| Date | Value |
|---|---|
| March 31, 2023 | 1.465M |
| December 31, 2022 | -30.65M |
| September 30, 2022 | 5.772M |
| June 30, 2022 | -7.118M |
| March 31, 2022 | -80.18M |
| December 31, 2021 | -0.137M |
| September 30, 2021 | -0.13M |
| June 30, 2021 | -1.504M |
| March 31, 2021 | -0.562M |
| December 31, 2020 | -0.456M |
| September 30, 2020 | -0.023M |
| June 30, 2020 | -1.001M |
| March 31, 2020 | -0.592M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Q32 Bio, Inc. | 0.00 |
| Beam Therapeutics, Inc. | -9.875M |
| C4 Therapeutics, Inc. | -14.82M |
| Cullinan Therapeutics, Inc. | 40.68M |
| Arrowhead Pharmaceuticals, Inc. | 43.68M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 45.92M |
| Cash from Financing (Quarterly) | 0.131M |
| Free Cash Flow | 26.71M |
| Free Cash Flow Per Share (Quarterly) | 7.920 |
| Free Cash Flow to Equity (Quarterly) | 46.07M |
| Free Cash Flow to Firm (Quarterly) | 45.92M |
| Free Cash Flow Yield | 28.16% |